Gemini Center for Sepsis Research at Institute of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway.
Faculty of Nursing and Health Sciences, Nord University, Levanger, Norway.
JAMA Psychiatry. 2023 Oct 1;80(10):1061-1065. doi: 10.1001/jamapsychiatry.2023.2717.
Insomnia has been associated with altered inflammatory response as well as increased risk of infections and sepsis in observational studies. However, these studies are prone to bias, such as residual confounding. To further understand the potential causal association between insomnia and sepsis risk, a 2-sample Mendelian randomization (MR) approach should be explored.
To evaluate whether genetically predicted insomnia is associated with risk of sepsis.
DESIGN, SETTING, AND PARTICIPANTS: Two-sample MR was performed to estimate the association between genetically predicted insomnia and sepsis risk. Data were obtained from a genome-wide association study identifying 555 independent genetic variants (R2 < 0.01) strongly associated with insomnia (P < 5 × 10-8). Sensitivity analyses were conducted to address bias due to pleiotropy and sample overlap, along with mediation analyses and sex-stratified analyses. The insomnia data set included 2.4 million individuals of European ancestry from the UK Biobank and 23andMe. For sepsis, 462 918 individuals of European ancestry from the UK Biobank were included. Data were extracted between February and December 2022 and analyzed between March 2022 and March 2023.
Genetically predicted insomnia.
Sepsis.
There were 593 724 individuals with insomnia and 10 154 cases of sepsis. A doubling in the population prevalence of genetically predicted insomnia was associated with an odds ratio of 1.37 (95% CI, 1.19-1.57; P = 7.6 × 10-6) for sepsis. Sensitivity analyses supported this observation. One-third of the association between genetically predicted insomnia and risk of sepsis was mediated through a combination of cardiometabolic risk factors for sepsis (body mass index, type 2 diabetes, smoking, or cardiovascular disease; overall proportion, 35.2%; 95% CI, 5.1-76.9). The association between insomnia and sepsis was more pronounced among women compared with men (women: odds ratio, 1.44; 95% CI, 1.24-1.68; men: OR, 1.10; 95% CI, 0.86-1.40).
The concordance between these findings and previous observational studies supports that insomnia is potentially causally associated with the risk of sepsis. Thus, insomnia is a potential preventable risk factor of sepsis that should be further investigated, also in non-European populations.
在观察性研究中,失眠与炎症反应改变以及感染和败血症风险增加有关。然而,这些研究容易受到残余混杂因素的影响。为了进一步了解失眠与败血症风险之间潜在的因果关联,应该采用双样本孟德尔随机化(MR)方法进行研究。
评估遗传预测的失眠是否与败血症风险相关。
设计、设置和参与者:采用双样本 MR 方法评估遗传预测的失眠与败血症风险之间的关联。研究数据来自一项全基因组关联研究,该研究确定了 555 个独立的遗传变异(R2<0.01),这些变异与失眠有很强的关联(P<5×10-8)。进行敏感性分析以解决由于多效性和样本重叠引起的偏倚,以及中介分析和性别分层分析。失眠数据集包括来自英国生物库的 240 万欧洲血统个体和 23andMe 的数据。败血症数据集中包括来自英国生物库的 462918 名欧洲血统个体。数据于 2022 年 2 月至 12 月提取,并于 2022 年 3 月至 2023 年 3 月进行分析。
遗传预测的失眠。
败血症。
共有 593724 名个体患有失眠症,10154 例发生败血症。遗传预测的失眠症在人群中的患病率增加一倍,与败血症的比值比为 1.37(95%CI,1.19-1.57;P=7.6×10-6)。敏感性分析支持这一观察结果。遗传预测的失眠症与败血症风险之间的关联有三分之一是通过败血症的代谢风险因素(体重指数、2 型糖尿病、吸烟或心血管疾病)的组合介导的(总体比例为 35.2%;95%CI,5.1-76.9)。与男性相比,失眠症与败血症之间的关联在女性中更为明显(女性:比值比,1.44;95%CI,1.24-1.68;男性:OR,1.10;95%CI,0.86-1.40)。
这些发现与之前观察性研究的一致性支持了失眠症与败血症风险之间可能存在因果关系。因此,失眠症是败血症的一个潜在可预防风险因素,应该进一步研究,包括非欧洲人群。